Tesamorelin - Body-composition support

What happens next

A calm, online process

Treatment availability depends on eligibility and clinician review. Nothing on this page guarantees prescribing, approval, or specific outcomes.

Complete your intake

A short intake captures the context your provider needs to review your file.

Clinician chart review

A licensed clinician reviews your information and approves, requests more, or declines treatment.

Discreet fulfillment

When prescribed, fulfillment is handled through the partnered pharmacy with discreet packaging.

Treatment is determined by a licensed clinician after review. Not all patients are candidates. Individual results vary.

About Tesamorelin

What it is, how it works, what it's studied for, and safety considerations.

What Is Tesamorelin?

Tesamorelin is a growth hormone–releasing hormone (GHRH) analog. FDA-approved tesamorelin products are indicated for reducing excess abdominal fat in adults with HIV and lipodystrophy. Outside that specific approved context, tesamorelin is framed as clinician-reviewed and is not implied to be FDA-approved for general fat loss, bodybuilding, anti-aging, or wellness.

How It Works

Tesamorelin stimulates pituitary growth hormone release through the GHRH receptor, which can increase IGF-1. In its approved context, it is used to reduce excess visceral abdominal fat in adults with HIV-associated lipodystrophy. It is not the same as directly administering growth hormone.

What It’s Studied For

Tesamorelin is supported by FDA labeling for HIV-associated lipodystrophy. It has been studied for visceral adipose tissue reduction, effects on IGF-1, glucose-related considerations, and safety concerns such as fluid retention and neoplasm risk considerations.

How It May Be Used in a Clinician-Supervised Program

A licensed clinician may consider tesamorelin only after reviewing goals, metabolic status, HIV/lipodystrophy context if relevant, glucose/diabetes risk, malignancy history, IGF-1 levels or concerns, pregnancy status, and medication list. It is not sold as a simple weight-loss injection.

Preferred Starting Options / Dosing Notes

Many patients begin with a lower starting option so a licensed clinician can evaluate tolerance, medical history, goals, and safety factors before any adjustments are considered. The starting option shown below is informational and reflects available program data, not self-directed dosing instructions. Final medication, dose, frequency, and treatment plan are determined by a licensed clinician.

Average starting option

5 mg

Available options

5 mg
10 mg
20 mg

Provider note: Do not change dose, frequency, or route of use unless directed by your clinician.

Safety Considerations

Increased risk of neoplasms and elevated IGF-1.
Fluid retention, glucose intolerance or diabetes mellitus, hypersensitivity, and injection-site reactions.
Contraindication in pregnancy for the labeled product context.
Active malignancy, pregnancy, uncontrolled diabetes, or significant fluid retention require careful review.

Important note

Some treatments may involve compounded medications when prescribed by a clinician. Compounded medications are not FDA-approved. The FDA does not evaluate compounded medications for safety, effectiveness, or quality before marketing.

Frequently Asked Questions

Is Tesamorelin guaranteed to be prescribed?

No. Prescriptions are never guaranteed. A licensed clinician reviews your medical intake and determines whether treatment is medically appropriate.

Can my provider change my treatment or dose?

Yes. Your selected treatment and preferred starting option are treated as preferences. Your provider may approve your selection, recommend a different option, adjust dosing, request more information, or deny treatment.

Does payment guarantee treatment?

No. Payment does not guarantee approval, a prescription, a specific medication, or a specific dose.

How is Tesamorelin used?

Use instructions are provided only if treatment is prescribed. If prescribed, follow your clinician's dosing and administration instructions exactly.

Are compounded medications FDA-approved?

No. Some treatments may involve compounded medications when prescribed by a clinician. Compounded medications are not FDA-approved and are not evaluated by FDA for safety, effectiveness, or quality before marketing.

What comes with injectable treatments if prescribed?

When prescribed by a licensed clinician, injectable peptide treatments may ship with syringes, prep pads for sterilization, and an instructions and dosing guide. Use only as directed by your clinician.

Disclaimer

Although the information on this page is based on available educational research and product information, it is provided for informational purposes only and is not medical advice. Treatment decisions, medication selection, dosing, and eligibility are determined by a licensed clinician after review. Not all patients are candidates, and individual results may vary. Use medications only as directed by your clinician.

Important safety information

This page is informational and does not replace medical advice from a licensed professional. Treatment availability depends on eligibility, clinician review, and applicable requirements. ElliotMeds does not provide emergency medical services — if you are experiencing a medical emergency, call 911 or go to the nearest emergency room.